Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study.
暂无分享,去创建一个
N. Aaronson | M. Muller | E. Wouters | E. Schoon | G. T. ten Velde | M. Demedts | F. Erdkamp | H. Hillen | G. Blijham | H. Schouten | J. Vansteenkiste | J. Smeets | B. M. Drenth | J. Simons | E. G. Cobben | N. K. Aaronson | J F Vansteenkiste | M J Muller | B M Drenth | F L Erdkamp | E G Cobben | E J Schoon | J B Smeets | H C Schouten | H. F. Hillen | G. H. Blijham | E. F. Wouters
[1] Jacob Cohen. Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.
[2] S. Kaasa,et al. The European Organisation for Research and Treatment of Cancer (EORTC) modular approach to quality of life assessment in oncology: an update. , 1995 .
[3] S. Kaasa,et al. Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy. , 1994, International journal of radiation oncology, biology, physics.
[4] S. Joel,et al. A double blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia. , 1993, British Journal of Cancer.
[5] D. Osoba,et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.
[6] J. Aisner,et al. Megestrol acetate in cancer anorexia and weight loss , 2010, Cancer.
[7] J. Feliu,et al. Usefulness of Megestrol Acetate in Cancer Cachexia and Anorexia: A Placebo‐Controlled Study , 1992, American journal of clinical oncology.
[8] H. Schmoll,et al. Megestrol acetate in cancer cachexia. , 1991, Seminars in oncology.
[9] E. Bruera,et al. A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer , 1990, Cancer.
[10] D. Schaid,et al. Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. , 1990, Journal of the National Cancer Institute.
[11] D. Schaid,et al. A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia , 1990, Cancer.
[12] R. Elashoff,et al. Hydrazine sulfate influence on nutritional status and survival in non-small-cell lung cancer. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] J. Aisner,et al. High-dose megestrol acetate. A possible treatment for cachexia. , 1986, JAMA.
[14] E. Bruera,et al. Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. , 1985, Cancer treatment reports.
[15] F. Cavalli,et al. Randomized trial of low- versus high-dose medroxyprogesterone acetate in the induction treatment of postmenopausal patients with advanced breast cancer. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] Joseph R. Bertino,et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. , 1980, The American journal of medicine.
[17] M. Shils. Principles of nutritional therapy , 1979, Cancer.
[18] R. Hahn,et al. Corticosteroid therapy of preterminal gastrointestinal cancer , 1974, Cancer.
[19] G. Bodey,et al. Causes of death in cancer patients , 1974 .